Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets

Journal of Biological Chemistry

Volumn 288, Issue 47, 2013, Pages 33997-34008

  Larsson, Mikael ^a   Vorrsjo, Evelina ^a   Talmud, Philippa ^b   Lookene, Aivar ^c   Olivecrona, Gunilla ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATOR PROTEINS; HYDROPHOBIC AMINO ACIDS; IRREVERSIBLE INACTIVATION; LIPOLYTIC ACTIVITY; MOLECULAR MECHANISM; PROTECTIVE EFFECTS; SITE DIRECTED MUTAGENESIS; TRIGLYCERIDE-RICH LIPOPROTEINS;

AMINO ACIDS; EMULSIFICATION; LIPOPROTEINS;

ENZYME ACTIVITY;

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 4; APOLIPOPROTEIN C1; APOLIPOPROTEIN C3; CHYLOMICRON; INTRALIPID; LIPOPROTEIN LIPASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ENZYME INACTIVATION; ENZYME INHIBITION; LIPOLYSIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS;

APOLIPOPROTEIN C-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS; DYSLIPIDEMIA; LIPOLYSIS; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIPOPROTEIN METABOLISM; TRIGLYCERIDE;

ANGIOPOIETINS; ANIMALS; APOLIPOPROTEIN C-I; APOLIPOPROTEIN C-III; CATTLE; EMULSIONS; HUMANS; LIPOLYSIS; LIPOPROTEIN LIPASE; MUTAGENESIS, SITE-DIRECTED; TRIGLYCERIDES;

EID: 84888335913     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.495366     Document Type: Article

References (74)

1. Wang, H., and Eckel, R. H. (2009) Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 297, E271-E288
2. Olivecrona, G., and Olivecrona, T. (2010) Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 21, 409-415
3. Beisiegel, U., Weber, W., and Bengtsson-Olivecrona, G. (1991) Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. U. S. A. 88, 8342-8346
4. Fojo, S. S., and Brewer, H. B. (1992) Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J. Intern. Med. 231, 669-677
5. Pollin, T. I., Damcott, C. M., Shen, H., Ott, S. H., Shelton, J., Horenstein, R. B., Post, W., McLenithan, J. C., Bielak, L. F., Peyser, P. A., Mitchell, B. D., Miller, M., O'Connell, J. R., and Shuldiner, A. R. (2008) A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322, 1702-1705
6. Maeda, N., Li, H., Lee, D., Oliver, P., Quarfordt, S. H., and Osada, J. (1994) Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269, 23610-23616
7. Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., and Breslow, J. L. (1990) Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249, 790-793
8. Wei, J., Ouyang, H., Wang, Y., Pang, D., Cong, N. X., Wang, T., Leng, B., Li, D., Li, X., Wu, R., Ding, Y., Gao, F., Deng, Y., Liu, B., Li, Z., Lai, L., Feng, H., Liu, G., and Deng, X. (2012) Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII. FEBS J. 279, 91-99
9. Ding, Y., Wang, Y., Zhu, H., Fan, J., Yu, L., Liu, G., and Liu, E. (2011) Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII. Transgenic Res. 20, 867-875
10. Brown, W. V., and Baginsky, M. L. (1972) Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem. Biophys. Res. Commun. 46, 375-382
11. Havel, R. J., Kane, J. P., and Kashyap, M. L. (1973) Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J. Clin. Invest. 52, 32-38
12. Krauss, R. M., Herbert, P. N., Levy, R. I., and Fredrickson, D. S. (1973) Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ. Res. 33, 403-411
13. Wang, C. S., McConathy, W. J., Kloer, H. U., and Alaupovic, P. (1985) Modulation oflipoprotein lipase activity by apolipoproteins. Effectof apolipoprotein C-III. J. Clin. Invest. 75, 384-390
14. Sundaram, M., Zhong, S., Bou Khalil, M., Links, P. H., Zhao, Y., Iqbal, J., Hussain, M. M., Parks, R. J., Wang, Y., and Yao, Z. (2010) Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions. J. Lipid Res. 51, 150-161
15. Ebara, T., Ramakrishnan, R., Steiner, G., and Shachter, N. S. (1997) Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia isnot mediated by effects on apolipoprotein E. J. Clin. Invest. 99, 2672-2681
16. Sehayek, E., and Eisenberg, S. (1991) Mechanisms ofinhibitionby apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266, 18259-18267
17. Bensadoun, A., Ehnholm, C., Steinberg, D., and Brown, W. V. (1974) Purification and characterization of lipoprotein lipase from pig adipose tissue. J. Biol. Chem. 249, 2220-2227
18. Ostlund-Lindqvist, A. M., and Iverius, P. H. (1975) Activation of highly purified lipoprotein lipase from bovine milk. Biochem. Biophys. Res. Commun. 65, 1447-1455
19. Ekman, R., and Nilsson-Ehle, P. (1975) Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue. Clin. Chim. Acta 63, 29-35
20. Simonet, W. S., Bucay, N., Pitas, R. E., Lauer, S. J., and Taylor, J. M. (1991) Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J. Biol. Chem. 266, 8651-8654
21. Shachter, N. S., Ebara, T., Ramakrishnan, R., Steiner, G., Breslow, J. L., Ginsberg, H. N., and Smith, J. D. (1996) Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. J. Clin. Invest. 98, 846-855
22. Jong, M. C., Hofker, M. H., and Havekes, L. M. (1999) Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol. 19, 472-484
23. Berbée, J. F., Van Der Hoogt, C. C., Sundararaman, D., Havekes, L. M., and Rensen, P. C. (2005) Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. J. Lipid Res. 46, 297-306
24. Van Der Hoogt, C. C., Berbée, J. F. P., Espirito Santo, S. M.., Gerritsen, G., Krom, Y. D., Van Der Zee, A., Havekes, L. M., Van Dijk, K. W., and Rensen, P. C. N. (2006) Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice. Biochim. Biophys. Acta 1761, 213-220
25. Sukonina, V., Lookene, A., Olivecrona, T., and Olivecrona, G. (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activityin adipose tissue. Proc. Natl. Acad. Sci. U. S. A. 103, 17450-17455
26. Nilsson, S. K., Anderson, F., Ericsson, M., Larsson, M., Makoveichuk, E., Lookene, A., Heeren, J., and Olivecrona, G. (2012) Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4. Biochim. Biophys. Acta 1821, 1370-1378
27. Lichtenstein, L., Mattijssen, F., De Wit, N. J., Georgiadi, A., Hooiveld, G. J., Van Der Meer, R., He, Y., Qi, L., Köster, A., Tamsma, J. T., Tan, N. S., Muller, M., and Kersten, S. (2010) Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab. 12, 580-592
28. Georgiadi, A., Lichtenstein, L., Degenhardt, T., Boekschoten, M. V., Van Bilsen, M., Desvergne, B., Muller, M., and Kersten, S. (2010) Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor/3/S and protects against fatty acid-induced oxidative stress. Circ. Res. 106, 1712-1721
29. Kroupa, O., Vorrsjo, E., Stienstra, R., Mattijssen, F., Nilsson, S. K., Sukonina, V., Kersten, S., Olivecrona, G., and Olivecrona, T. (2012) Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue. BMC Physiol. 12, 13
30. Bengtsson-Olivecrona, G., and Olivecrona, T. (1991) Phospholipase activity of milk lipoprotein lipase. Methods Enzymol. 197, 345-356
31. Olivecrona, G., and Lookene, A. (1997) Noncatalytic functions of lipoprotein lipase. Methods Enzymol. 286, 102-116
32. Shen, Y., Lookene, A., Nilsson, S., and Olivecrona, G. (2002) Functional analyses of human apolipoprotein CII by site-directed mutagenesis: identification of residues important for activation of lipoprotein lipase. J. Biol. Chem. 277, 4334-4342
33. Hultin, M., Savonen, R., and Olivecrona, T. (1996) Chylomicron metabolism in rats: lipolysis, recirculation of triglyceride-derived fatty acids in plasma FFA, and fate of core lipids as analyzed by compartmental modelling. J. Lipid Res. 37, 1022-1036
34. Astrup, H. N, and Bengtsson, G. (1982) Activator proteins for lipoprotein lipase from bovine plasma: preparation by adsorption to Intralipid. Comp. Biochem. Physiol. B 72, 487-491
35. Liu, H., Talmud, P. J., Lins, L., Brasseur, R., Olivecrona, G., Peelman, F., Vandekerckhove, J., Rosseneu, M., and Labeur, C. (2000) Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase. Biochemistry 39, 9201-9212
36. Bengtsson-Olivecrona, G., and Olivecrona, T. (1992) Assay of lipoprotein lipase and hepatic lipase. in Lipoprotein Analysis: A Practical Approach (Converse, C. A., and Skinner, E. R., eds), pp. 169-185, Oxford University Press, Cary, NC
37. Sreerama, N, and Woody, R. W. (2000) Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 287, 252-260
38. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948
39. Bergo, M., Olivecrona, G., and Olivecrona, T. (1996) Forms of lipoprotein lipase in rat tissues: in adipose tissue the proportion of inactive lipase increases on fasting. Biochem. J. 313, 893-898
40. Bengtsson, G., and Olivecrona, T. (1977) Stimulation and inhibition of milk (lipoprotein) lipase by proteins from egg yolk lipoproteins. Eur. J. Biochem. 79, 225-231
41. Fielding, C. J., and Fielding, P. E. (1976) Chylomicron protein content and the rate of lipoprotein lipase activity. J. Lipid Res. 17, 419-423
42. Jackson, R. L., Tajima, S., Yamamura, T., Yokoyama, S., and Yamamoto, A. (1986) Comparison of apolipoprotein C-II-deficient triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphatidylcholine-stabilized particles as substrates for lipoprotein lipase. Biochim. Biophys. Acta 875, 211-219
43. Gangabadage, C S., Zdunek, J., Tessari, M., Nilsson, S., Olivecrona, G., and Wijmenga, S. S. (2008) Structure and dynamics of human apolipoprotein CIII. J. Biol. Chem. 283, 17416-17427
44. Massey, J. B., Gotto, A. M., Jr., and Pownall, H. J. (1979) Contribution of a helix formation in human plasma apolipoproteins to their enthalpy of association with phospholipids. J. Biol. Chem. 254, 9559-9561
45. Bengtsson, G., and Olivecrona, T. (1979) Binding of deoxycholate to lipoprotein lipase. Biochim. Biophys. Acta 575, 471-474
46. Wang, L., Atkinson, D., and Small, D. M. (2003) Interfacial properties of an amphipathic a-helix consensus peptide of exchangeable apolipoproteins at air/water and oil/water interfaces. J. Biol. Chem. 278, 37480-37491
47. Protter, A. P., Vigne, J.-L., Mallory, J. B., Talmadge, K. D., and Kane, J. P. (July 24, 1990) Mature apoai protein production under serum free culturing conditions. U. S. Patent 4, 349, 629
48. Formisano, S., Brewer, H. B., Jr., and Osborne, J. C., Jr. (1978) Effect of pressure and ionic strength on the self-association of Apo-A-I from the human high density lipoprotein complex. J. Biol. Chem. 253, 354-359
49. Washington, C., and Davis, S. S. (1988) The production of parenteral feeding emulsions by Microfluidizer. Int. J. Pharm. 44, 169-176
50. Jackson, R. L., Pattus, F., and Demel, R. A. (1979) Interaction of plasma apolipoproteins with lipid monolayers. Biochim. Biophys. Acta 556, 369-387
51. Krebs, K. E., Phillips, M. C., and Sparks, C. E. (1983) A comparison of the surface activities of rat plasma apolipoproteins C-II, C-III-0, C-III-3. Biochim. Biophys. Acta 751, 470-473
52. Ibdah, J. A., Krebs, K. E., and Phillips, M. C. (1989) The surface properties of apolipoproteins A-I and A-II at the lipid/water interface. Biochim. Biophys. Acta 1004, 300-308
53. Weinberg, R. B., Ibdah, J. A., and Phillips, M. C. (1992) Adsorption of apolipoprotein A-IV to phospholipid monolayers spread at the air/water interface: a model for its labile binding to high density lipoproteins. J. Biol. Chem. 267, 8977-8983
54. Meyers, N. L., Wang, L., and Small, D. M. (2012) Apolipoprotein C-I binds more strongly to phospholipid/triolein/water than triolein/water interfaces: a possible model for inhibiting cholesterol ester transfer protein activity and triacylglycerol-rich lipoprotein uptake. Biochemistry 51, 1238-1248
55. Demel, R. A., Dings, P. J., and Jackson, R. L. (1984) Effectofmonolayer lipid structure and composition on the lipoprotein lipase-catalyzed hydrolysis of triacylglycerol. Biochim. Biophys. Acta 793, 399-407
56. Jackson, R. L., Balasubramaniam, A., Murphy, R. F., and Demel, R. A. (1986) Interaction of synthetic peptides of apolipoprotein C-II and lipoprotein lipase at monomolecular lipid films. Biochim. Biophys. Acta 875, 203-210
57. Olivecrona, G., and Beisiegel, U. (1997) Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons. Arterioscler. Thromb. Vasc. Biol. 17, 1545-1549
58. Fredenrich, A., Giroux, L. M., Tremblay, M., Krimbou, L., Davignon, J., and Cohn, J. S. (1997) Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J. Lipid Res. 38, 1421-1432
59. Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Veilleux, L., Rodriguez, C., Bernier, L., Mamer, O., and Davignon, J. (2002) Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects. J. Lipid Res. 43, 1680-1687
60. Sparrow, J. T., Pownall, H. J., Hsu, F. J., Blumenthal, L. D., Culwell, A. R., and Gotto, A. M. (1977) Lipid binding by fragments of apolipoprotein C-III-1 obtained by thrombin cleavage. Biochemistry 16, 5427-5431
61. Lambert, D. A., Catapano, A. L., Smith, L. C., Sparrow, J. T., and Gotto, A. M., Jr. (1996) Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles. Atherosclerosis 127, 205-212
62. Von Eckardstein, A., Holz, H., Sandkamp, M., Weng, W., Funke, H., and Assmann, G. (1991) Apolipoprotein C-III (Lys58 3 Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. J. Clin. Invest. 87, 1724-1731
63. Liu, H., Labeur, C., Xu, C. F., Ferrell, R., Lins, L., Brasseur, R., Rosseneu, M., Weiss, K. M., Humphries, S. E., and Talmud, P. J. (2000) Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr. J. Lipid Res. 41, 1760-1771
64. Mattijssen, F., and Kersten, S. (2012) Regulation of triglyceride metabolism by Angiopoietin-like proteins. Biochim. Biophys. Acta1 821, 782-789
65. Yu, X., Burgess, S. C., Ge, H., Wong, K. K., Nassem, R. H., Garry, D. J., Sherry, A. D., Malloy, C. R., Berger, J. P., and Li, C. (2005) Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proc. Natl. Acad. Sci. U. S. A. 102, 1767-1772
66. Garcia-Arcos, I., Hiyama, Y., Drosatos, K., Bharadwaj, K. G., Hu, Y., Son, N. H., O'Byrne, S. M., Chang, C. L., Deckelbaum, R. J., Takahashi, M., Westerterp, M., Obunike, J. C., Jiang, H., Yagyu, H., Blaner, W. S., and Goldberg, I. J. (2013) Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology. J. Biol. Chem. 288, 14046-14058
67. Hansen, J. B., Fernández, J. A., Notø, A. T., Deguchi, H., Björkegren, J., and Mathiesen, E. B. (2011) The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis. J. Lipids 2011, 271062
68. Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., and Wahli, W. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 275, 28488-28493
69. Attman, P. O., Alaupovic, P., and Gustafson, A. (1987) Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int. 32, 368-375
70. Baranowski, T., Kralisch, S., Bachmann, A., Lössner, U., Kratzsch, J., Blüher, M., Stumvoll, M., and Fasshauer, M. (2011) Serum levels of the adipokine fasting-induced adipose factor/angiopoietin-like protein 4 depend on renal function. Horm. Metab. Res. 43, 117-120
71. Crawford, G. A., Savdie, E., and Stewart, J. H. (1979) Heparin-released plasma lipasesinchronic renal failure and after renal transplantation. Clin. Sci. (Lond.) 57, 155-165
72. Attman, P. O., and Samuelsson, O. (2009) Dyslipidemia of kidney disease. Curr. Opin. Lipidol. 20, 293-299
73. Sundaram, M., Zhong, S., Bou Khalil, M., Zhou, H., Jiang, Z. G., Zhao, Y., Iqbal, J., Hussain, M. M., Figeys, D., Wang, Y., and Yao, Z. (2010) Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia. J. Lipid Res. 51, 1524-1534
74. Qin, W., Sundaram, M., Wang, Y., Zhou, H., Zhong, S., Chang, C. C., Manhas, S., Yao, E. F., Parks, R. J., McFie, P. J., Stone, S. J., Jiang, Z. H. G., Wang, C., Figeys, D., Jia, W., and Yao, Z. (2011) Missense mutation in APOC3 within the C-terminal lipid binding domain of human apoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins. Evidence that apoC-III plays a major role in the formation of lipid precursors within the microsomal lumen. J. Biol. Chem. 286, 27769-27780